scholarly article | Q13442814 |
P50 | author | Tommy Nyberg | Q42601699 |
Michael J Zelefsky | Q51936867 | ||
Chandana A Reddy | Q57617472 | ||
Jonathan I. Epstein | Q88404078 | ||
P2093 | author name string | Andrew J Vickers | |
Victor E Reuter | |||
Lars Egevad | |||
James A Eastham | |||
Misop Han | |||
Eric A Klein | |||
Anil V Parwani | |||
Samson W Fine | |||
Daniel D Sjoberg | |||
Joel B Nelson | |||
Cristina Magi-Galluzzi | |||
Peter Wiklund | |||
Jay P Ciezki | |||
P2860 | cites work | Long-term functional outcomes after treatment for localized prostate cancer | Q30542816 |
Radical prostatectomy or watchful waiting in early prostate cancer | Q33985455 | ||
Prognostic Gleason grade grouping: data based on the modified Gleason scoring system | Q34610101 | ||
Addressing overdiagnosis and overtreatment in cancer: a prescription for change | Q35067706 | ||
Radical prostatectomy versus observation for localized prostate cancer | Q36194308 | ||
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma | Q36227180 | ||
Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades | Q36318643 | ||
Gleason score 6 adenocarcinoma: should it be labeled as cancer? | Q36449197 | ||
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? | Q37280719 | ||
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes? | Q38005257 | ||
When is prostate cancer really cancer? | Q38203988 | ||
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System | Q38613858 | ||
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. | Q38789947 | ||
Gleason inflation 1998-2011: a registry study of 97,168 men. | Q39199397 | ||
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy | Q39724803 | ||
Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"? | Q39834875 | ||
Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates | Q42135518 | ||
Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system | Q43164671 | ||
Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence | Q45123395 | ||
Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations | Q46455001 | ||
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease | Q46735412 | ||
Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. | Q50636330 | ||
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. | Q50951455 | ||
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 | ||
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer | Q57860471 | ||
Prognosis of prostatic carcinoma | Q67580156 | ||
Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging | Q69737582 | ||
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy | Q73164185 | ||
Observation for clinically localized prostate cancer | Q87460194 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 428-435 | |
P577 | publication date | 2015-07-10 | |
P1433 | published in | European Urology | Q15763991 |
P1476 | title | A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score | |
P478 | volume | 69 |